Contact
Request a Callback
Webinar: SARS-COV-2 Omicron Variant of Concern
Join us on December 14th at 11 am EST/8 am PST for a webinar featuring VIGILINT Emergency Medicine Physicians Drs Ossmann and Cellini as they discuss the newly discovered omicron variant and the potential impact on holiday travel. You have questions, and we want to hear from you! Please submit your questions you’d like addressed… Continue reading Webinar: SARS-COV-2 Omicron Variant of Concern
COVID-19 Vaccine for Children & The Pandemic’s Impact on Working Parents
COVID-19 Vaccine Approved for Children 5-11 Kids 5 and up can now get their age-appropriate dose of the COVID-19 vaccine, which is the most effective way to protect against the virus—hard stop. After a year that saw parents scrambling to find ways to protect their children from illness and keep their kids educated in a… Continue reading COVID-19 Vaccine for Children & The Pandemic’s Impact on Working Parents
White House Announces “Path out of the Pandemic”
Today, President Biden announced a six-pronged national strategy to expand the federal government’s response to COVID-19. The Department of Labor is developing a rule that will require all employers with 100 or more employees to ensure their workers are fully vaccinated and require unvaccinated workers to be tested on a weekly basis. In addition, employers… Continue reading White House Announces “Path out of the Pandemic”
The Debate: Masks in Schools
As summer draws to a close, fall brings unique challenges. The surge of COVID-19 cases, instigated by the Delta variant, has heavily impacted the beginning of the new school year. In July, the CDC recommended that all students and staff wear masks in schools, regardless of vaccination status. The nature of this statement as a… Continue reading The Debate: Masks in Schools
COVID-19 ONE YEAR LATER, Part II: Testing and Vaccines
In the second part of VIGILINT’s two-part series COVID-19 1 Year Later, VIGILINT Ops Analyst and blogger Colin Schilly dives into the two critical hallmarks of the pandemic. Testing and vaccines. The development and rollout of several effective vaccines in under a year offer great hope for the pandemic’s end. Sadly, that day may still… Continue reading COVID-19 ONE YEAR LATER, Part II: Testing and Vaccines
COVID-19 ONE YEAR LATER, Part I: The Best and Worst Handlings of the COVID-19 Crisis
On January 10, 2020, VIGILINT first reported a new strain of a coronavirus connected to a cluster of pneumonia cases linked to Wuhan, China. No one could have predicted the year that would follow. As of publishing, worldwide cases have reached 104 million with 2.27 million deaths. VIGILINT looks back at the critical events that… Continue reading COVID-19 ONE YEAR LATER, Part I: The Best and Worst Handlings of the COVID-19 Crisis
COVID-19 Transmission: Surfaces
There is some risk of COVID-19 transmission from surfaces, but the primary disease transfer mode is airborne transmission. Several studies have analyzed the detection of COVID-19 on various surfaces. One such study, published by the New England Journal of Medicine in March 2020, largely shaped the discussion around SARS-COV-2 (the virus causing COVID-19 disease) transmissions… Continue reading COVID-19 Transmission: Surfaces
COVID-19 Update: Vaccine Distribution
The Trump administration is reversing its COVID-19 vaccination strategy by authorizing the release of Pfizer-BioNtech and Moderna’s federally stockpiled vaccines. The previous policy withheld half the purchased doses to ensure the supply necessary for second doses, and states could only receive vaccines based on their adult population size. The new distribution strategy unveiled yesterday is intended… Continue reading COVID-19 Update: Vaccine Distribution
VIGILINT Travel Notice: COVID-19 Testing for International Flights to the United States
COVID-19 TESTING FOR INTERNATIONAL FLIGHTS TO THE UNITED STATES 14 January 2021
